Rheumatology News

This month’s featured roundtable on the evolving and broadening role of advanced practice providers in rheumatologic care is a timely discussion, and I give a big thanks to Carrie Beach, BSN, RN-BC; Jeffrey Curtis, MD, MS, MPH; Amanda Mixon, PA-C; Kenneth G. Saag, MD; and Christine Stamatos, DNP, ANP-C.

The number, and role, of advanced practice providers in rheumatology care is exploding.

The concept of delayed gratification has been ingrained in us throughout medical school and residency. This mentality can sometimes lead to explosive spending as an attending when one enjoys a significant salary boost.

Skin manifestations are common in VEXAS syndrome and evaluating their presentations can assist in genotyping the disease and possibly lead to better diagnoses, according to a study.

The Council for Medical Specialty Societies, or CMSS, announced the launch of a new initiative that aims to reduce clinicians’ reliance on race in clinical decision-making and patient harms.

A possible genetic rationale for why women acquire more autoimmune diseases than men has been discovered, according to findings published recently in Cell.

Early use of biologics like belimumab may limit complications associated with steroid use and improve long-term outcomes in systemic lupus erythematosus, according to data presented at the EULAR 2024 Congress.

Rheumatoid arthritis and fibromyalgia are among the most common comorbidities identified in patients following a diagnosis of osteoarthritis, according to data presented at the EULAR 2024 Congress.

Most pediatric patients with Sjögren’s disease displayed an interferon signature in their blood and parotid gland tissue, which could help confirm diagnoses and shorten treatment delays, according to data presented at EULAR 2024 Congress.

New survey results from the AMA illustrate the burden of prior authorization, with many physicians reporting that it leads to serious patient harms, delays care, reduces work productivity and more.